disulfiram has been researched along with Bone Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, Y | 1 |
| Lin, Y | 1 |
| Chen, J | 1 |
| Jin, Y | 1 |
| Wang, K | 1 |
| Michelakos, T | 1 |
| Wang, B | 1 |
| Shang, Z | 1 |
| DeLeo, AB | 1 |
| Duan, Z | 1 |
| Hornicek, FJ | 1 |
| Schwab, JH | 1 |
| Wang, X | 1 |
| Guo, W | 1 |
| Zhang, X | 1 |
| Lin, L | 1 |
| Wang, H | 1 |
| He, E | 1 |
| Wang, G | 1 |
| Zhao, Q | 1 |
3 other studies available for disulfiram and Bone Cancer
| Article | Year |
|---|---|
Disulfiram Chelated with Copper Promotes Apoptosis in Osteosarcoma via ROS/Mitochondria Pathway.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Chelating Agents; Copper; Disulfiram; Humans; | 2021 |
Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
Topics: AC133 Antigen; Aldehyde Dehydrogenase; Animals; Bone Neoplasms; Cell Line, Tumor; Chondrosarcoma; Co | 2021 |
The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Prolife | 2021 |